ARTICLE | Financial News
On April 13, the companies each received an undisclosed award from the Thiel Foundation’s Breakout Labs program. SciBac is developing therapeutics to treat antibiotic-resistant diseases using the microbiome. Gel4Med is developing an antimicrobial tissue-scaffolding matrix. Envisagenics uses machine learning to analyze DNA and RNA sequencing, and LogicInk is developing wearable diagnostic technology...